Phototherapy and PUVA photochemotherapy in children

Photodermatology Photoimmunology and Photomedicine

Volumn 20, Issue 2, 2004, Pages 69-75

  Holme, S A ^a,b   Anstey, A V ^a  

^a ROYAL GWENT HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Children; Eczema; Phototherapy; Polymorphic light eruption (PLE); Psoriasis; PUVA; Treatment; UVA; UVB; Vitiligo

Indexed keywords

CORTICOSTEROID; METHOXSALEN; PSORALEN;

CANCER RISK; CARCINOGENESIS; CARCINOGENICITY; CATARACT; CHILD; CHILDHOOD DISEASE; DRUG ABSORPTION; ERYTHEMA; GASTROINTESTINAL TOXICITY; HEALTH CARE FACILITY; HUMAN; LENTIGO; MELANOMA; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; PUVA; REVIEW; SKIN CANCER; SKIN DISEASE; XEROSIS;

CHILD; HUMANS; PHOTOTHERAPY; PUVA THERAPY; RISK FACTORS; SKIN DISEASES;

EID: 1842536529     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2004.00084.x     Document Type: Review

References (62)

1. Holman CD, Armstrong BK. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: An analysis separating histogenic types. J Natl Cancer Inst 1984; 73: 75-82.
2. Holly EA, Aston DA, Cress RD. Cutaneous melanoma in women: I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol 1995; 141: 923-933.
3. Young AR. Carcinogenicity of UVB assessed. 1995; 345:1431-1432.
4. Stern RS. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 2001; 44: 755-761.
5. Stern RS, Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 1988; 91: 120-124.
6. Anderson TF. Pediatric phototherapy. Symposium on paediatric dermatology. Ped Clin North Am 1983; 30: 701-717.
7. Tay Y-K, Morelli JG, Weston WL. Experience with UVB in children. Ped Dermatol 1996; 13: 406-409.
8. Esterley N, Atherton D, Cohen B. Phototherapy for children (symposium). Ped Dermatol 1996; 13: 415-426.
9. Dodd KL. Children first - the Audit Commission study of hospital services. Arch Dis Child 1993; 69: 173-175.
10. Gelmetti C, Caputo R. Psoriasis in childhood. In: Dubertrret L, ed. Psoriasis. Brescia: ISED, 1994; 248-260.
11. Lerman S, Megaw J, Willis I. Potential ocular complications from PUVA therapy and their prevention. J Invest Dermatol 1980; 74: 197-199.
12. Halpern SM, Anstey AV, Dawe RS, et al. Guidelines for topical PUVA: A report of a workshop of the British Photodermatology Group. Br J Dermatol 2000; 142: 22-31.
13. British Photodermatology Group. British photodermatology group guidelines for PUVA. Br J Dermatol 1994; 130: 246-255.
14. Stern RS, Weinstein MC, Baker SG. Risk reduction for non-melanoma skin cancer with childhood sunscreen use. Arch Dermatol 1986; 122: 537-545.
15. Burden AD. Management of psoriasis in childhood. Clin Exp Dermatol 1999; 24: 341-345.
16. Wahl A, Moum T, Hanestad BR, Wiklund I. The relationship between demographic and clinical variables, and quality of life aspects in patients with psoriasis. Qual Life Res 1999; 8: 319-326.
17. van Weelden H, Baart de la Faille H, Young E, van der Leun JC. Comparison of narrow-band UVB phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Derm Venereol 1990; 70: 212-215.
18. Al-Fouzan AS, Nanda A. UVB phototherapy in childhood psoriasis. Ped Dermatol 1995; 12: 66.
19. Jeckler J, Larkö O. UVB phototherapy of atopic dermatitis. Br J Dermatol 1988; 119: 697-705.
20. Collins P, Ferguson J. Narrowband (TL-01) UVB air-conditioned phototherapy for atopic eczema in children. Br J Dermatol 1995; 133: 653-664.
21. Jeckler J, Larkö O. Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: A paired comparison study. J Am Acad Dermatol 1990; 22: 49-53.
22. Jeckler J, Larkö O. UVA solarium vs UVB phototherapy of atopic dermatitis; a paired comparison study. Br J Dermatol 1991; 125: 569-572.
23. 1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992; 26: 225-230.
24. Sheehan M, Atherton D, Norris P, Hawk J. Oral psoralen photochemotherapy in severe childhood atopic eczema. Br J Dermatol 1993; 129: 431-436.
25. Grimes PE, Kelly AP. Management of vitiligo in children. Ped Dermatol 1986; 3: 498-510.
26. Mai DW, Omohundro C, Dijkstra J, et al. Childhood vitiligo successfully treated with bath PUVA. Ped Dermatol 1998; 15: 53-55.
27. Anstey A, Hawk JL. Quelle est la place de la puvathérapie dans le traitement du vitiligo? Ann Dermatol Véneréol 1994; 121: 273-278.
28. Lerner MR, Fitzpatrick TB, Halder RM, Hawk JL. Discussion of a case of vitiligo. Photodermatol Photoimmunol Photomed 1999; 15: 41-44.
29. Scherschun L, Kim JJ, Lim HW. Narrow-band ultaviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44: 999-1003.
30. Njoo MD, Bos JD, Westerhof W. Treatment of generalised vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-253.
31. Mastalier U, Kerl H, Wolf P. Clinical, laboratory, phototest and phototherapy findings in polymorphic light eruption: A retrospective study of 133 patients. Eur J Dermatol 1998; 8: 554-559.
32. Man I, Dawe RS, Ferguson J. Artificial hardening for polymorphic light eruption: Practical points from ten years' experience. Photodermatol Photoimmunol Photomed 1999; 15: 96-99.
33. Bilsland D, George SA, Gibbs NK, et al. A comparison of narrow-band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol 1993; 129: 708-712.
34. Collins P, Ferguson J. Narrowband UVB phototherapy (TL-01): an effective preventative treatment for the photodermatoses. Br J Dermatol 1995; 132: 956-963.
35. Gupta G, Man I, Kemmett D. Hydroa vacciniforme: A clinical and follow-up study of 17 cases. J Am Acad Dermatol 2000; 42: 208-213.
36. Lee DY, Young JI, Park MH, Chung J-H. Actinic prurigo: limited effect of PUVA. Br J Dermatol 1997; 136: 972-973.
37. Roelandts R. Photo(chemo)therapy and general management of erythropoietic protoporphyria. Dermatol 1995; 190: 330-331.
38. Todd DJ. Erythropoietic protoporphyria. Br J Dermatol 1994; 131: 751-766.
39. Pašic A, Ceovi R, Lipozencic J, et al. Phototherapy in pediatric patients. Ped Dermatol 2003; 20: 71-77.
40. Romaní J, Puig L, Fernández MT, et al. Pityriasis lichenoides in children: Clinicopathologic review of 22 patients. Ped Dermatol 1998; 15: 1-6.
41. Todd D, Askari A, Ektaish F. PUVA therapy for disabling pansclerotic morphoea of children. Br J Dermatol 1998; 138: 201-202.
42. Wollina U, Looks A, Uhlemann C, Wollina K. Pansclerotic morphoea of childhood - follow-up over 6 years. Ped Dermatol 1999; 16: 245-247.
43. Kerscher M, Volkenandt M, Gruss C, et al. Low-dose UVA1 phototherapy for treatment of localised scleroderma. J Am Acad Dermatol 1998; 38: 21-26.
44. Stege H, Berneburg M, Humke S, et al. High-dose UVA1 radiation therapy for localised scleroderma. J Am Acad Dermatol 1997; 36: 938-944.
45. Gruss C, Stucker M, Kobyletzki G, et al. Low dose UVA1 phototherapy in disabling pansclerotic morphoea of childhood. Br J Dermatol 1997; 136: 293-294.
46. Kreuter A, Gambichler T, Avermaete A, et al. Combined treatment with calicipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphoea. Ped Dermatol 2001; 18: 241-245.
47. Kreuter A, Jansen T, Stücker M, et al. Low-dose ultraviolet-A1 phototherapy for lichen sclerosus et atrophicus. Clin Exp Dermatol 2001; 26: 30-32.
48. Godt O, Proksch E, Streit V, Christophers E. Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis. Dermatol 1997; 195: 35-39.
49. Christophers E, Hönigsmann H, Wolff K, Langner A. PUVA-treatment of urticaria pigmentosa. Br J Dermatol 1978; 98: 701-702.
50. Smith ML, Orton PW, Chu H, Weston WL. Photochemotherapy of dominant, diffuse, cutaneous mastocytosis. Ped Dermatol 1990; 7: 251-255.
51. Park Y-K, Park HY, Bang DS, Cho CK. Subcorneal pustular dermatosis treated with phototherapy. Int J Dermatol 1986; 25: 124-126.
52. Volkenandt M, Kerscher M, Sander C, et al. PUVA-bath photochemotherapy resulting in rapid clearance of lymphomatoid papulosis in a child. Arch Dermatol 1995; 131: 1094.
53. Wiesmann A, Weller A, Lischka G, et al. Treatment of acute graft-versus-host disease with PUVA: Results of a pilot study. Bone Marrow Transplant 1999; 23: 151-155.
54. Aubin F, Brion A, Deconinck E, et al. Phototherapy in the treatment of cutaneous graft-versus-host disease. Transplant 1995; 59: 151-155.
55. Vogelsang GB, Wolff D, Altomonte V. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). Bone Marrow Transplant 1996; 17: 1061-1067.
56. Enk CD, Elad S, Vexler A, et al. Chronic graft-versus-host disease treated with UVB phototherapy. Bone Marrow Transplant 1998; 22: 1179-1183.
57. Di Landro A, Marchesi L, Naldi L, et al. A case of hypopigmented mycosis fungoides in a young Caucasian boy. Ped Dermatol 1997; 14: 449-452.
58. Tay Y-K, Weston WL, Aeling JL. Treatment of childhood cutaneous T-cell lymphoma with alpha-interferon plus PUVA. Ped Dermatol 1996; 13: 496-500.
59. Pabsch H, Rütten A, von Stemm A, et al. Treatment of childhood mycosis fungoides with topical PUVA. J Am Acad Dermatol 2002; 47: 557-561.
60. Meister L, Duarte AM, Davis J, et al. Sézary syndrome in an 11-year-old girl. J Am Acad Dermatol 1993; 28: 93-95.
61. Healy E, Rogers S. PUVA treatment for alopecia areata - does it work? A retrospective review of 102 cases. Br J Dermatol 1993; 129: 42-44.
62. Alabdulkareem AS, Abahussein AA, Okoro A. Minimal benefit from photochemotherapy for alopecia areata. Int J Dermatol 1996; 35: 890-891.